Results
1 -
10 of
64
(Click
here to explore results)
- Tofacitinib and peficitinib inhibitors of Janus kinase for autoimmune disease treatment: a quantum biochemistry approach. Jackson L. Amaral, Naiara C. Lucredi, Victor L. B. França, Samuel J. M. Santos, Francisco F. Maia, Pablo A. Morais, Pedro F. N. Souza, Jurandir F. Comar, Valder N. Freire
, Phys. Chem. Chem. Phys.
, 2024
, 26
, 13420
- Development of a sensitive biochemical assay for the detection of tofacitinib adherence. Stephanie Church, Kimme L. Hyrich, Kayode Ogungbenro, Richard D. Unwin, Anne Barton, James Bluett
, Anal. Methods
, 2023
, 15
, 1797
- A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment via inhibiting JAK-STAT and JNK signalling pathways. Ziqian Wang, Chenyue Zhan, Fang Zeng, Shuizhu Wu
, Nanoscale
, 2020
, 12
, 23013
- STAT3/IL-6 dependent induction of inflammatory response in osteoblast and osteoclast formation in nanoscale wear particle-induced aseptic prosthesis loosening. Zhantao Deng, Ruiying Zhang, Mengyuan Li, Shuai Wang, Guangtao Fu, Jiewen Jin, Zhenheng Wang, Yuanchen Ma, Qiujian Zheng
, Biomater. Sci.
, 2021
, 9
, 1291
- A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors. Silke M. Bauer, Matthias Gehringer, Stefan A. Laufer
, Anal. Methods
, 2014
, 6
, 8817
- Rational design of reversible and irreversible cysteine sulfenic acid-targeted linear C-nucleophiles. Vinayak Gupta, Kate S. Carroll
, Chem. Commun.
, 2016
, 52
, 3414
- Design, synthesis and evaluation of (R)-3-(7-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. Chieyeon Chough, Sunmin Lee, Misuk Joung, Jaemin Lee, Jong Hoon Kim, B. Moon Kim
, Med. Chem. Commun.
, 2018
, 9
, 477
- The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
- SARS-CoV-2-induced disruption of a vascular bed in a microphysiological system caused by type-I interferon from bronchial organoids. Kazuya Fujimoto, Yoshikazu Kameda, Yuta Nagano, Sayaka Deguchi, Takuya Yamamoto, Rafal P. Krol, Peter Gee, Yasufumi Matsumura, Toru Okamoto, Miki Nagao, Kazuo Takayama, Ryuji Yokokawa
, Lab Chip
, 2024
- Prioritization of rheumatoid arthritis risk subpathways based on global immune subpathway interaction network and random walk strategy. Wenhua Lv, Qiuyu Wang, He Chen, Yongshuai Jiang, Jiajia Zheng, Miao Shi, Yanjun Xu, Junwei Han, Chunquan Li, Ruijie Zhang
, Mol. BioSyst.
, 2015
, 11
, 2986